查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1967701

宠物肥胖管理市场－全球产业规模、份额、趋势、机会、预测：依动物类型、产品、通路、地区和竞争格局划分，2021-2031年

Pet Obesity Management Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Animal Type, By Product, By Distribution Channel, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

全球宠物肥胖管理市场预计将从 2025 年的 116.1 亿美元成长到 2031 年的 171.6 亿美元，复合年增长率为 6.73%。

此领域涵盖旨在减轻伴侣动物体重的治疗性营养补充剂、药物介入和物理復健服务。推动该领域发展的关键因素包括宠物日益人性化、人们对肥胖相关併发症（如糖尿病和骨关节炎）的认识不断提高，以及透过专业体重管理来改善久坐生活方式以延长宠物寿命的必要性。

市场概览
预测期 2027-2031
市场规模：2025年 116.1亿美元
市场规模：2031年 171.6亿美元
复合年增长率：2026-2031年 6.73%
成长最快的细分市场 补充
最大的市场 北美洲

儘管存在这些积极因素，但宠物实际健康状况与饲主认知之间的巨大差距阻碍了市场扩张。许多饲主未能准确识别宠物肥胖，导致治疗延误和对饮食限制的依从性不足。根据宠物肥胖预防协会 (APOP) 2024 年的数据，只有 35% 的狗主饲主33% 的猫饲主认为他们的宠物超重或肥胖，这凸显了临床实际情况与饲主认知之间的差距。这种认知差距限制了专业管理解决方案的消费群。

市场驱动因素

全球宠物肥胖症的日益普遍是推动市场扩张和专业体重管理干预措施需求成长的主要动力。随着过量摄取卡路里和缺乏运动成为普遍现象，与体重相关的疾病（例如代谢紊乱和骨关节炎）的激增迫使兽医专业人员实施严格的管理通讯协定。根据英国宠物食品协会发布的《2024年肥胖症报告》，兽医专业人员估计，英国目前有50%的犬和43%的猫超重或肥胖，这使得低热量处方粮和復健服务的需求急剧上升。

同时，可支配收入的成长和宠物医疗保健支出的增加，在将医疗保健需求转化为市场收入方面发挥着至关重要的作用。随着宠物越来越被拟人化，饲主也越来越愿意投资于高品质的兽医护理和处方粮，以延长宠物的寿命。根据美国宠物用品协会 (APPA) 发布的《2024-2025 年全美宠物饲主调查》，2023 年美国宠物产业的总支出达到 1,470 亿美元，这表明医疗费用支出潜力巨大。这种经济基础为治疗方案的推广提供了支持。宠物肥胖预防协会 (APOP) 在 2024 年 5 月发布的报告显示，16% 的狗主饲主25% 的猫饲主使用治疗性减重粮。

市场挑战

全球宠物肥胖管理市场面临的一个根本限制因素是宠物实际身体状况与其饲主认知之间存在显着差距。这种差异严重阻碍了市场渗透，因为不了解宠物体重问题的饲主不太可能寻求药物干预或购买治疗性营养补充剂。由于无法识别超重问题，导致无法进行必要的兽医咨询以製定管理方案，使得大量临床上可治疗的动物无法被製造商接触到，儘管肥胖症的患病率很高，从而抑制了市场需求。

产业数据也印证了这项障碍的严重性。英国宠物食品公司2024年的报告显示，兽医专业人士将50%的犬隻和43%的猫咪归类为超重或肥胖，而77%的饲主却认为自己的宠物体重健康。这种鲜明的对比表明，绝大多数潜在消费者并不了解宠物的健康需求，市场也未能充分利用肥胖病例的实际规模。因此，阻碍收入成长的并非缺乏有效的治疗方法，而是终端使用者无法辨识问题的根源。

市场趋势

GLP-1受体促效剂的出现标誌着宠物减肥市场的转捩点，使其从传统的饮食限制转变为类似于人类肥胖症治疗的药物干预。这些长效注射药物利用生物机制来调节食慾和改善代谢功能，为严格的饮食管理提供了替代方案。根据《宠物食品产业》杂誌2025年4月的一篇报导，如果处方减重药的安全性和有效性得到证实，大约三分之一的饲主愿意为宠物使用此类药物。这表明，随着越来越多的饲主将体重管理纳入医疗范畴以降低健康风险，此类药物很可能迅速普及。

同时，穿戴式宠物活动追踪器的引入正在改变宠物体重管理策略。其优点在于能够提供客观的能量消耗数据，进而帮助宠物克服久坐的习惯。与主观观察不同，这些设备利用加速计技术监测活动量和卡路里消耗，使兽医能够根据即时指标制定精准的运动计画。这项技术有助于建立回馈机制，增强饲主的参与度和对康復通讯协定的依从性。 Tractive 于 2025 年 1 月发布的一份报告也印证了这一趋势，该报告指出，使用其追踪解决方案的活跃用户数量已超过 130 万。

目录

第一章概述

第二章：调查方法

第三章执行摘要

第四章：客户心声

第五章：全球宠物肥胖管理市场展望

  • 市场规模及预测
    • 按金额
  • 市占率及预测
    • 动物种类（狗、猫、其他）
    • 副产品（治疗性食品、补充品）
    • 分销通路（宠物专卖店、电子商务、其他）
    • 按地区
    • 按公司（2025 年）
  • 市场地图

第六章：北美宠物肥胖管理市场展望

  • 市场规模及预测
  • 市占率及预测
  • 北美洲：国别分析
    • 我们
    • 加拿大
    • 墨西哥

第七章：欧洲宠物肥胖管理市场展望

  • 市场规模及预测
  • 市占率及预测
  • 欧洲：国别分析
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙

第八章：亚太地区宠物肥胖管理市场展望

  • 市场规模及预测
  • 市占率及预测
  • 亚太地区：国别分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第九章：中东与非洲宠物肥胖管理市场展望

  • 市场规模及预测
  • 市占率及预测
  • 中东与非洲：国别分析
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非

第十章：南美洲宠物肥胖管理市场展望

  • 市场规模及预测
  • 市占率及预测
  • 南美洲：国别分析
    • 巴西
    • 哥伦比亚
    • 阿根廷

第十一章 市场动态

  • 促进因素
  • 任务

第十二章 市场趋势与发展

  • 併购
  • 产品发布
  • 近期趋势

第十三章：全球宠物肥胖管理市场：SWOT分析

第十四章：波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的议价能力
  • 顾客权力
  • 替代品的威胁

第十五章 竞争格局

  • Mars Incorporated
  • Hill's Pet Nutrition, Inc.
  • Nestle SA
  • Farmina Pet Foods Holding BV
  • Drools Pet Food Pvt. Ltd.
  • NOW Health Group, Inc.
  • Virbac SA
  • VioVet Ltd
  • Rolf C. Hagen Inc.
  • Vivaldis Health & Foods Pvt. Ltd.
  • Neogen Corporation

第十六章 策略建议

第十七章：关于研究公司及免责声明

简介目录
Product Code: 27321

The Global Pet Obesity Management Market is projected to expand from USD 11.61 Billion in 2025 to USD 17.16 Billion by 2031, registering a CAGR of 6.73%. This sector encompasses therapeutic nutritional formulations, pharmaceutical interventions, and physical rehabilitation services aimed at reducing excess body weight in companion animals. Growth is largely propelled by the increasing humanization of pets, a growing awareness of obesity-linked comorbidities like diabetes and osteoarthritis, and the need to address sedentary lifestyles through professional weight management to enhance pet longevity.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 11.61 Billion
Market Size 2031USD 17.16 Billion
CAGR 2026-20316.73%
Fastest Growing SegmentSupplements
Largest MarketNorth America

Despite these positive indicators, market expansion is hindered by a significant disconnect between actual pet health and owner perception. Many pet parents fail to identify overweight conditions accurately, resulting in delayed treatment and poor adherence to dietary restrictions. Data from the Association for Pet Obesity Prevention in 2024 reveals that only 35% of dog owners and 33% of cat owners classified their pets as overweight or obese, highlighting a gap between clinical reality and owner recognition that limits the consumer base for professional management solutions.

Market Driver

The increasing global prevalence of pet obesity acts as the primary catalyst for market expansion, necessitating professional weight management interventions. As caloric overconsumption and sedentary behaviors become normalized, the surge in weight-related pathologies, such as metabolic dysfunction and osteoarthritis, compels veterinary professionals to implement rigorous management protocols. According to the 'Obesity Report 2024' by UK Pet Food, veterinary professionals estimate that 50% of dogs and 43% of cats in the United Kingdom are currently overweight or obese, creating a non-discretionary demand for specialized low-calorie formulations and rehabilitation services.

Concurrently, rising disposable income and dedicated pet healthcare expenditure are crucial in translating medical needs into market revenue. As pet humanization intensifies, owners show a greater willingness to invest in premium veterinary care and prescription diets to prolong their companions' lives. The American Pet Products Association's '2024-2025 National Pet Owners Survey' reported total U.S. pet industry expenditures of $147 billion in 2023, indicating a strong capacity for healthcare spending. This financial readiness supports the adoption of therapeutic solutions, with the Association for Pet Obesity Prevention reporting in May 2024 that 16% of dog owners and 25% of cat owners utilized therapeutic weight-loss diets.

Market Challenge

A fundamental restraint on the Global Pet Obesity Management Market is the substantial disparity between actual pet body condition and owner perception. This cognitive disconnect severely limits market penetration, as owners who fail to recognize weight issues are unlikely to seek pharmaceutical interventions or purchase therapeutic nutritional formulations. The inability to identify excess weight precludes necessary veterinary consultations for prescribing management solutions, thereby rendering a significant portion of the clinically addressable population inaccessible to manufacturers and suppressing demand despite the high prevalence of obesity.

Industry data underscores the magnitude of this obstacle, with UK Pet Food reporting in 2024 that while veterinary professionals classified 50% of dogs and 43% of cats as overweight or obese, 77% of owners believed their pets were at a healthy weight. This stark contrast illustrates that a vast majority of potential consumers remain unaware of their pet's medical needs, preventing the market from capitalizing on the actual volume of obesity cases. Consequently, revenue growth is impeded not by the absence of effective treatments, but by the end-user's inability to acknowledge the underlying problem.

Market Trends

The emergence of GLP-1 receptor agonist medications marks a transformative shift in the market, transitioning from traditional caloric restriction to pharmaceutical interventions comparable to human obesity treatments. These long-acting injectables leverage biological mechanisms to regulate appetite and enhance metabolic function, offering an alternative to strict dietary compliance. According to an April 2025 article by PetfoodIndustry, approximately one in three pet owners expressed willingness to use prescription weight-loss drugs for their pets if proven safe and effective, signaling a high potential for rapid adoption as owners increasingly medicalize weight management to mitigate health risks.

Simultaneously, the integration of wearable pet activity trackers is reshaping weight management strategies by offering objective data on energy expenditure to counter sedentary habits. Unlike subjective observations, these devices employ accelerometer technology to monitor activity levels and caloric burn, allowing veterinarians to design precise exercise regimens based on real-time metrics. This technology fosters a feedback loop that enhances owner engagement and adherence to rehabilitation protocols, a trend evidenced by Tractive's report in January 2025 of having over 1.3 million active subscribers utilizing their tracking solutions.

Key Market Players

  • Mars Incorporated
  • Hill's Pet Nutrition, Inc.
  • Nestle S.A
  • Farmina Pet Foods Holding B.V.
  • Drools Pet Food Pvt. Ltd.
  • NOW Health Group, Inc.
  • Virbac S.A.
  • VioVet Ltd
  • Rolf C. Hagen Inc.
  • Vivaldis Health & Foods Pvt. Ltd.
  • Neogen Corporation

Report Scope

In this report, the Global Pet Obesity Management Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Pet Obesity Management Market, By Animal Type

  • Dogs
  • Cats
  • Others

Pet Obesity Management Market, By Product

  • Therapeutic Food
  • Supplements

Pet Obesity Management Market, By Distribution Channel

  • Pet Specialty Stores
  • E-Commerce
  • Others

Pet Obesity Management Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Pet Obesity Management Market.

Available Customizations:

Global Pet Obesity Management Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Pet Obesity Management Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Animal Type (Dogs, Cats, Others)
    • 5.2.2. By Product (Therapeutic Food, Supplements)
    • 5.2.3. By Distribution Channel (Pet Specialty Stores, E-Commerce, Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Pet Obesity Management Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Animal Type
    • 6.2.2. By Product
    • 6.2.3. By Distribution Channel
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Pet Obesity Management Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Animal Type
        • 6.3.1.2.2. By Product
        • 6.3.1.2.3. By Distribution Channel
    • 6.3.2. Canada Pet Obesity Management Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Animal Type
        • 6.3.2.2.2. By Product
        • 6.3.2.2.3. By Distribution Channel
    • 6.3.3. Mexico Pet Obesity Management Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Animal Type
        • 6.3.3.2.2. By Product
        • 6.3.3.2.3. By Distribution Channel

7. Europe Pet Obesity Management Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Animal Type
    • 7.2.2. By Product
    • 7.2.3. By Distribution Channel
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Pet Obesity Management Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Animal Type
        • 7.3.1.2.2. By Product
        • 7.3.1.2.3. By Distribution Channel
    • 7.3.2. France Pet Obesity Management Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Animal Type
        • 7.3.2.2.2. By Product
        • 7.3.2.2.3. By Distribution Channel
    • 7.3.3. United Kingdom Pet Obesity Management Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Animal Type
        • 7.3.3.2.2. By Product
        • 7.3.3.2.3. By Distribution Channel
    • 7.3.4. Italy Pet Obesity Management Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Animal Type
        • 7.3.4.2.2. By Product
        • 7.3.4.2.3. By Distribution Channel
    • 7.3.5. Spain Pet Obesity Management Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Animal Type
        • 7.3.5.2.2. By Product
        • 7.3.5.2.3. By Distribution Channel

8. Asia Pacific Pet Obesity Management Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Animal Type
    • 8.2.2. By Product
    • 8.2.3. By Distribution Channel
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Pet Obesity Management Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Animal Type
        • 8.3.1.2.2. By Product
        • 8.3.1.2.3. By Distribution Channel
    • 8.3.2. India Pet Obesity Management Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Animal Type
        • 8.3.2.2.2. By Product
        • 8.3.2.2.3. By Distribution Channel
    • 8.3.3. Japan Pet Obesity Management Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Animal Type
        • 8.3.3.2.2. By Product
        • 8.3.3.2.3. By Distribution Channel
    • 8.3.4. South Korea Pet Obesity Management Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Animal Type
        • 8.3.4.2.2. By Product
        • 8.3.4.2.3. By Distribution Channel
    • 8.3.5. Australia Pet Obesity Management Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Animal Type
        • 8.3.5.2.2. By Product
        • 8.3.5.2.3. By Distribution Channel

9. Middle East & Africa Pet Obesity Management Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Animal Type
    • 9.2.2. By Product
    • 9.2.3. By Distribution Channel
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Pet Obesity Management Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Animal Type
        • 9.3.1.2.2. By Product
        • 9.3.1.2.3. By Distribution Channel
    • 9.3.2. UAE Pet Obesity Management Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Animal Type
        • 9.3.2.2.2. By Product
        • 9.3.2.2.3. By Distribution Channel
    • 9.3.3. South Africa Pet Obesity Management Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Animal Type
        • 9.3.3.2.2. By Product
        • 9.3.3.2.3. By Distribution Channel

10. South America Pet Obesity Management Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Animal Type
    • 10.2.2. By Product
    • 10.2.3. By Distribution Channel
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Pet Obesity Management Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Animal Type
        • 10.3.1.2.2. By Product
        • 10.3.1.2.3. By Distribution Channel
    • 10.3.2. Colombia Pet Obesity Management Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Animal Type
        • 10.3.2.2.2. By Product
        • 10.3.2.2.3. By Distribution Channel
    • 10.3.3. Argentina Pet Obesity Management Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Animal Type
        • 10.3.3.2.2. By Product
        • 10.3.3.2.3. By Distribution Channel

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Pet Obesity Management Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Mars Incorporated
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Hill's Pet Nutrition, Inc.
  • 15.3. Nestle S.A
  • 15.4. Farmina Pet Foods Holding B.V.
  • 15.5. Drools Pet Food Pvt. Ltd.
  • 15.6. NOW Health Group, Inc.
  • 15.7. Virbac S.A.
  • 15.8. VioVet Ltd
  • 15.9. Rolf C. Hagen Inc.
  • 15.10. Vivaldis Health & Foods Pvt. Ltd.
  • 15.11. Neogen Corporation

16. Strategic Recommendations

17. About Us & Disclaimer